These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 13788171)

  • 1. Studies on the active center of monoamine oxidase.
    ZELLER EA
    Experientia; 1960 Sep; 16():399-402. PubMed ID: 13788171
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the in vivo inhibition of brain and liver monoamine oxidase as produced by beta-phenylisopropylhydrazine (PIH) and iproniazid.
    GOGERTY JH; HORITA A
    J Pharmacol Exp Ther; 1960 Aug; 129():357-60. PubMed ID: 13850477
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurochemical correlates of behavior II. Correlation of brain monoamine oxidase activity with behavioural changes after iproniazid and 5-hydroxytryptophan administration.
    APRISON MH; FERSTER CB
    J Neurochem; 1961 Mar; 6():350-7. PubMed ID: 13683915
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibition "in vitro" of monoamine oxidase].
    NARANJO R
    Rev Asoc Medica Mex; 1960 Jun; 40():272-9. PubMed ID: 14426018
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the adrenergic action of iproniazid, inhibitor of monoamine oxidase].
    MEYER F
    C R Hebd Seances Acad Sci; 1961 Apr; 252():2616-8. PubMed ID: 13769974
    [No Abstract]   [Full Text] [Related]  

  • 6. Physiological significance of monoamine oxidase.
    IMAIZUMI R; OMORI K; UNOKI A; SANO K; WATARI Y; NAMBA J; INUI K
    Jpn J Pharmacol; 1959 Mar; 8():87-95. PubMed ID: 13852733
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of iproniazid on monoamines and monamine oxidase in human brain.
    GANROT PO; ROSENGREN E; GOTTFRIES CG
    Experientia; 1962 Jun; 18():260-1. PubMed ID: 13896669
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 9. [On quantitative differences in the effect between 1-isonicotinoyl-2-isopropyl hydrazine (iproniazid) and isopropyl hydrazine on monoamine oxidase].
    HEIM F; DIEMER K
    Med Exp Int J Exp Med; 1960; 3():249-51. PubMed ID: 13712856
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine.
    GREEN H; SAWYER JL
    J Pharmacol Exp Ther; 1960 Jul; 129():243-9. PubMed ID: 13851489
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurophysiological studies with monoamine oxidase inhibitors.
    SCHALLEK W
    Dis Nerv Syst; 1960 Mar; 21(3)Suppl():64-6. PubMed ID: 14442400
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine.
    HESS SM; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1959 Nov; 127():178-81. PubMed ID: 14401504
    [No Abstract]   [Full Text] [Related]  

  • 13. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
    HORITA A
    Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854
    [No Abstract]   [Full Text] [Related]  

  • 14. Accumulation of serotonin in the brain of reserpine-treated mice after inhibition of monoamine oxidase: effect of body temperature.
    DUBNICK B; LEESON GA; CHESSIN M; SCOTT CC
    Arch Int Pharmacodyn Ther; 1960 Jun; 126():194-202. PubMed ID: 13818306
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanism of the irreversible inhibition of rat-liver monoamine oxidase by iproniazid (marsilid).
    DAVISON AN
    Biochem J; 1957 Oct; 67(2):316-22. PubMed ID: 13471553
    [No Abstract]   [Full Text] [Related]  

  • 16. [Iproniazid and other inhibitors of monoamine oxidase in the treatment of angina pectoris].
    ABAZA A; RUTLISBERGER PA
    Presse Med (1893); 1960 May; 68():1049-52. PubMed ID: 13791366
    [No Abstract]   [Full Text] [Related]  

  • 17. Amine oxidases. XIX. Inhibition of monoamine oxidase by phenylcyclopropylamines and iproniazid.
    ZELLER EA; SARKAR S
    J Biol Chem; 1962 Jul; 237():2333-6. PubMed ID: 14010087
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of trans-2-phenylcycloproplylamine upon norepinephrine concentration and monamine oxidase activity of rat brain.
    GREEN H; ERICKSON RW
    J Pharmacol Exp Ther; 1960 Jul; 129():237-42. PubMed ID: 13851486
    [No Abstract]   [Full Text] [Related]  

  • 19. [Our experiences with monoamine oxidase inhibiting substances].
    TAUBER CG
    Psychiatr Neurol (Basel); 1960 Jul; 140():148-51. PubMed ID: 13775480
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain.
    BRODIE BB; SPECTOR S; SHORE PA
    Ann N Y Acad Sci; 1959 Sep; 80():609-16. PubMed ID: 13804624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.